Innovation V. Ltd Neomed serves as Executive at Arsanis, Inc., where they oversee executive responsibilities. Since joining the company, Innovation V. Ltd Neomed has executed 4 insider transactions totaling $3.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 20, 2017 involved exercising options for 41,878 shares valued at $0.
Innovation V. Ltd Neomed currently holds 288,560 shares of Arsanis, Inc. (ASNS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Innovation V. Ltd Neomed has been a net buyer of ASNS stock. They have purchased $3.0M and sold $0 worth of shares.
Innovation V. Ltd Neomed's most recent insider trade was on Nov 20, 2017, when they sold 41,878 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 20, 2017 | ASNS | $3.0M | Purchase | 300,000 | $10.00 | Discretionary |
| Nov 20, 2017 | ASNS | $0 | Conversion | 246,682 | $N/A | Discretionary |